Skip to content
healthcare.dev

ZIOPTAN

NDC 82584-609, Tafluprost, solution/ drops, from Thea Pharma Inc..

Product NDC
82584-609
Status
Listed
Labeler
Thea Pharma Inc.
Dosage form
SOLUTION/ DROPS
Route
OPHTHALMIC
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA202514
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/82584-609 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TAFLUPROST.015 mg/mL

Pharmacologic classes

Increased Prostaglandin Activity [PE]; Prostaglandin Analog [EPC]; Prostaglandin Receptor Agonists [MoA]; Prostaglandins [CS]

Package NDCNDC-11Package
82584-609-30825840609303 POUCH in 1 CARTON (82584-609-30) / 10 VIAL, SINGLE-USE in 1 POUCH (82584-609-01) / .3 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/db529b54-2ac7-4020-9791-7333bbe6c90f
  • NADAC price for package 82584060930

    GET /v1/drugs/nadac/82584060930

Use it

Look up 82584-609 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/82584-609 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 82584-609. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.